On 29 December 2025, Ukraine's Cabinet of Ministers set the country's first import quota for medical cannabis substances: 592,168 grams of THC for 2026. For a Canadian Licensed Producer looking past Germany for new volume, that quota is a real opening, but only for one kind of product.
Exporting cannabis to Ukraine in 2026 means supplying cannabis substance to a licensed Ukrainian manufacturer or compounding pharmacy. Every shipment sits inside a government quota and needs an import permit from the State Service of Ukraine on Medicines and Drugs Control. Dried flower is not an approved dosage form for Ukrainian patients. A Canadian LP can still ship raw material, but only as a starting material that a Ukrainian licence holder turns into oral drops, capsules, gels or dental pastes.
Exporting cannabis to Ukraine: where the framework stands in 2026
Ukraine legalised medical cannabis through Law No. 3528-IX, signed in February 2024. It runs on the same treaty logic as every other import market: licences for each activity, annual quotas, and a permit for every shipment. What makes it different is the product list.
| Date | Milestone | What it means for a Canadian LP |
|---|---|---|
| February 2024 | Law No. 3528-IX signed | Legal basis for medical cannabis |
| 16 August 2024 | Law enters into force | Licensing and quota system starts |
| 2024 | Ministry of Health approves dosage forms | Drops, capsules, gels, dental pastes only |
| October 2024 | Licensing conditions approved, GACP required | Domestic growers will compete later |
| January 2025 | First cannabis medicine registered | Registration route proven (oral drops) |
| 2 June 2025 | First import permit issued | Import route proven, for a registered substance |
| 29 December 2025 | Resolution No. 1772 sets 2026 quotas | First volume ceiling for imports |
| 29 May 2026 | Ministry of Health Order No. 706 | Pharmacy manufacturing rules amended |
Read the gaps between those dates. The law took effect in August 2024. The first product registration came five months later, the first import permit ten months later, and the first cannabis quota sixteen months later. Each step depended on the one before it, and none of them moved faster than the slowest ministry.
The market is open and still early. Plan around the pace of Ukrainian ministries, which so far has been measured in months per step.
Why dried flower has no patient channel in Ukraine
The Ministry of Health approved four dosage forms in 2024: oral drops, hard capsules, gels and dental pastes. The first registered cannabis medicine, in January 2025, was a set of oral drops from a Spanish manufacturer. By October 2025, Prohibition Partners reported that every authorised product in Ukraine was extract-based and that flower was not authorised for medical use.
Patients also pay out of pocket. As of late 2025 there was no reimbursement mechanism, which keeps the prescribing base small and price-sensitive.
What this does to your product
A Ukrainian buyer pays for cannabinoid content it can extract, standardise and register. Bud structure, trim quality and terpene nose disappear once the material goes into an extraction vessel.
That changes the commercial maths. You'll be quoted on THC content and documentation quality, the same way an API buyer anywhere in pharma prices a starting material. If your margin depends on a premium flower price, Ukraine will compress it.
The flower-first export model that works in Germany or Australia does not transfer here. If you quote Ukraine, quote it as a raw-material buyer.
The Ukraine API supply path: 5 gates
Ukraine's 2026 quota covers three kinds of import: scientific use, the manufacture of APIs and medicinal products, and APIs authorised for compounding in pharmacies. A Canadian LP fits the second category. To get a shipment there, five gates have to open in order.
| Gate | Who holds it | Where LPs stall |
|---|---|---|
| 1. Licensed Ukrainian counterparty | Your buyer | Finding a buyer with a narcotics licence |
| 2. Substance registration | Your buyer, with your data | Dossier gaps in your batch records |
| 3. Quota headroom | Cabinet of Ministers | Annual ceiling shared by all importers |
| 4. Import permit | State Service of Ukraine | Issued strictly within quota limits |
| 5. Health Canada export permit | You | Needs the Ukrainian permit first |
Gates 1 and 2: the buyer carries the registration
Only licensed legal entities can handle medical cannabis in Ukraine. While domestic cultivation scales up, the government eased the import procedure for companies that already hold narcotics-handling licences, with import authorisations agreed with the Security Service of Ukraine. The first import permit, in June 2025, covered a substance already entered in the State Register of Medicinal Products. Treat that registration as supplier-specific until your partner's regulatory counsel confirms otherwise.
Gate 3: the quota counts THC, not product
Resolution No. 1772 sets the 2026 import quota at 592,168 grams of THC, alongside 493,535 grams for domestic production. At 20 percent THC, that import figure equals roughly 2,960 kg of raw material for every importer in the country combined. Ukraine's national quota sits on top of the international estimates system run by the INCB, which we cover in our guide to how INCB estimates work.
The export quota is 100 grams. That rules out using Ukraine as a re-export hub, the role some LPs give a Portuguese processing partner.
Gates 4 and 5: the permit chain
The State Service of Ukraine on Medicines and Drugs Control issues the import permit, and only within the quota. Your export permit from Health Canada under the Cannabis Act then has to match it, consignment by consignment. If the sequence is new to you, start with how the two-permit chain works and our walkthrough of the Health Canada export permit process.
Gate 2 is the one to plan for. Permits are administrative, while a registration dossier depends on the quality of your batch records.
When Ukraine makes sense for a Canadian LP
Ukraine's licensing conditions require GACP for domestic cultivation, with indoor growing, plant-level labelling, National Police security and an electronic system that tracks every movement of plants and substances. Expect a Ukrainian API buyer to hold an imported starting material to the same standard. Our GACP buyer checklist shows what that evidence looks like.
Here's our position. A Canadian LP that sells only finished dried flower should not commit regulatory budget to Ukraine in 2026. The product doesn't fit, the volume is capped, and the law already builds a domestic cultivation track that will compete with imports.
The calculation changes if you already supply bulk material to extractors, hold complete GMP-grade batch documentation, and can wait out a partner's registration timeline. Then Ukraine is worth a conversation, ideally alongside markets that do take flower, which we screen in our review of emerging import markets.
AlphaLeaf is a Montreal-based Health Canada Licensed Producer growing indoor, hand-trimmed cannabis from refined genetics. Every batch carries ISO/IEC 17025 test data and full traceability records, and we hold export authorisation under the Cannabis Act for licensed importers and pharmaceutical manufacturers across Europe.
Evaluating Ukraine or another API-led market? Talk to our export team before you build the dossier. The 2026 quota is set. Start with the documents.
Frequently Asked Questions
Can a Canadian LP export dried cannabis flower to Ukraine?
Not as a patient product. Ukraine's approved dosage forms are oral drops, hard capsules, gels and dental pastes, and dried flower is not authorised for medical use. A Canadian LP can supply cannabis as a starting material to a licensed Ukrainian manufacturer, inside the national quota.
Who issues cannabis import permits in Ukraine?
The State Service of Ukraine on Medicines and Drugs Control issues import permits, and only within the annual quotas set by the Cabinet of Ministers. The importer must hold the relevant narcotics-handling licence, and the Canadian exporter then needs a matching Health Canada export permit.
How large is Ukraine's 2026 medical cannabis import quota?
Resolution No. 1772, adopted on 29 December 2025, sets the 2026 import quota at 592,168 grams of THC. The figure counts THC content rather than product weight, and it is shared by every importer in Ukraine.
Does Ukraine reimburse medical cannabis?
No reimbursement mechanism existed as of late 2025, so patients pay out of pocket. That keeps demand price-sensitive and favours suppliers who can compete on cost per gram of THC.
Can Ukraine be used as a cannabis re-export hub?
No. Ukraine's 2026 export quota for THC is 100 grams, so the country works as a destination market only, unlike processing hubs such as Portugal.
Is commercial cannabis cultivation legal in Ukraine?
Yes, under licence. Cultivation must be indoors, follow GACP, use plant-level labelling and operate under a National Police security agreement, with every movement recorded in an electronic accounting system.
